Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISM II: Nuedexta for PBA in Dementia, Stroke, and TBI
NCT01799941Phase 4Completed
- Sponsor
- Avanir Pharmaceuticals
- Start
- Feb 2013
- Primary completion
- May 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dextromethorphan + quinidine in pseudobulbar affect (PBA), sponsored by Avanir Pharmaceuticals. Started Feb 2013; status: completed.
02
Drugs
dextromethorphan + quinidine
03
Conditions
pseudobulbar affect (PBA)
Beyond the preview
Go deeper on NCT01799941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01799941.